This announcement is a separate document:
嘉应制药：北京君合（杭州）律师事务所关于广东嘉应制药股份有限公司2024年第二次临时股东大会之法律意见书
Jiaying Pharmaceutical: Legal Opinion of Beijing Junhe (Hangzhou) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Guangdong Jiaying Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.